<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Fanconi <z:hpo ids='HP_0001903'>anemia</z:hpo> (FA) is a <z:e sem="disease" ids="C0019247" disease_type="Disease or Syndrome" abbrv="">genetic condition</z:e> associated with bone marrow (BM) failure, <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), and <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>We studied 57 FA patients with hypoplastic or <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (n = 20), <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (n = 18), <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> (n = 11), or no BM abnormality (n = 8) </plain></SENT>
<SENT sid="2" pm="."><plain>BM samples were analyzed by karyotype, high-density DNA arrays with respect to paired fibroblasts, and by selected oncogene sequencing </plain></SENT>
<SENT sid="3" pm="."><plain>A specific pattern of chromosomal abnormalities was found in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, which included 1q+ (44.8%), 3q+ (41.4%), -7/7q (17.2%), and 11q- (13.8%) </plain></SENT>
<SENT sid="4" pm="."><plain>Moreover, cryptic RUNX1/AML1 lesions (translocations, deletions, or mutations) were observed for the first time in FA (20.7%) </plain></SENT>
<SENT sid="5" pm="."><plain>Rare mutations of NRAS, FLT3-ITD, MLL-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PTD</z:e>, ERG amplification, and ZFP36L2-PRDM16 translocation, but no TP53, TET2, CBL, NPM1, and CEBPÎ± mutations were found </plain></SENT>
<SENT sid="6" pm="."><plain>Frequent homozygosity regions were related not to somatic copy-neutral loss of heterozygosity but to consanguinity, suggesting that homologous recombination is not a common progression mechanism in FA </plain></SENT>
<SENT sid="7" pm="."><plain>Importantly, the RUNX1 and other chromosomal/genomic lesions were found at the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> stages, except for 1q+, which was found at <z:hpo ids='HP_0000001'>all</z:hpo> stages </plain></SENT>
<SENT sid="8" pm="."><plain>These data have implications for staging and therapeutic managing in FA patients, and also to analyze the mechanisms of <z:e sem="disease" ids="C1516669" disease_type="Neoplastic Process" abbrv="">clonal evolution</z:e> and <z:e sem="disease" ids="C1326912" disease_type="Neoplastic Process" abbrv="">oncogenesis</z:e> in a background of genomic instability and BM failure </plain></SENT>
</text></document>